Soy Supplements in Treating Patients Undergoing Surgery for Localized Prostate Cancer
Completed · Phase 2 · Has a placebo group
Conditions studied: Prostate Cancer
In brief
RATIONALE: Dietary supplementation with soy may keep prostate cancer from growing in patients planning to undergo surgery. PURPOSE: This randomized phase II trial is studying a soy supplement to see how well it works compared to a placebo in treating patients undergoing surgery for localized prostate cancer.
Key facts
- Study ID
- NCT00345813
- Run by
- Wake Forest University Health Sciences
- People needed
- 62
- Starts
- 2003-10-01
- Expected to finish
- 2006-07-01
- Last updated by the study team
- 2018-08-10
Who can join
Age: 18 and older, up to 120. Sex: male. Healthy volunteers: not accepted.
Where it is running
- Wake Forest University Comprehensive Cancer Center — Winston-Salem, North Carolina, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.